165
Participants
Start Date
January 31, 2010
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
CM-AT
Single unit dose powder of active substance (CM-AT) administered 3 times per day for 90 days
Mount Sinai School of Medicine, Manhattan
Universtiy of Pittsburgh, Pittsburgh
Hershey Medical Center, Hershey
Drexel University, Philadelphia
University of North Carolina, Chapel Hill, Chapel Hill
Institute for Behavioral Medicine, Smyrna
Lake Mary Pediatrics, Orange City
Ohio State University, Columbus
Alexian Brothers Center for Psychiatric Research, Hoffman Estates
Louisiana State University, Shreveport
Oklahoma State University, Child Study Center, Oklahoma City
University of Texas, Houston, Houston
Ericksen Research & Development, Clinton
Southwest Autism Research and Resource Center, Phoenix
Neuropsychiatric Research Center of Orange County, Santa Ana
University of California, San Francisco, San Francisco
University of California, Davis, M.I.N.D. Institute, Sacramento
Cyn3rgy Research Center, Gresham
Saint Peter's University Hospital, New Brunswick
Lead Sponsor
Curemark
INDUSTRY